Since 1985, Clinical Research Institute has conducted over 800 phase II, III, and IV clinical studies in a variety of therapeutic areas including asthma, allergy, migraine, sinusitis, urticaria, atopic dermatitis, COPD, URI, influenza, and pneumonia. Our four Principal Investigators are Physicians board certified in Allergy and Immunology and they have each earned the designation of Certified Physician Investigator (CPI®) as determined by the Association of Pharmaceutical Physician Investigators (APPI).
Clinical research sites that wish to participate in clinical testing of Generic Drugs are required to self-identify with the FDA, pursuant to the Generic Drug User Fee Amendments of 2012 (GDUFA). Clinical Research Institute completed this certification in the first effective year and maintains its annual renewal each May. Sponsors may verify our annual renewal directly with the FDA at http://www.fda.gov/forindustry/userfees/genericdruguserfees/default.htm or you may contact us directly for our annual certification. This link also provides more specifics about GDUFA.
Our Research Staff:
Access to Large Patient Population: